title: Primary angioplasty in patients > or = 75 years old with ST-elevation myocardial infarction - one-year follow-up results.
abstract: BACKGROUND
  Efficacy and safety of primary percutaneous coronary angioplasty (PCI) in elderly patients with acute ST-elevation myocardial infarction (STEMI) have not yet been definitely established because these patients were usually excluded from large randomised trials.
  
  
  OBJECTIVE
  To evaluate in-hospital and one-year outcome after primary PCI in elderly patients, and to assess clinical characteristics of this group.
  
  
  METHODS
  The study population included 1061 consecutive STEMI patients, mean age 60.6+/-17 years, treated with primary PCI. Clinical characteristics and results of 127 patients aged > or = 75 years were compared to the younger group.
  
  
  RESULTS
  Elderly patients were more frequently female (48.4 vs. 23.6%, p <0.005) and diabetics (22.2 vs. 12.1%, p <0.02) and more frequently had renal and/or left ventricular failure (22.3 vs. 9.1%, and 9.1 vs. 4.5%, p <0.005, respectively). In older patients less frequently stents were implanted and TIMI flow 3 was restored (65.1 vs. 78.8%, p <0.05 and 74.6 vs. 84.7%, p <0.03). In-hospital mortality in older versus younger patients was 11.8 vs. 3.0%, p <0.005. The incidence of in-hospital complications (stroke, major bleeding and reinfarction) was similar in both groups. The one-year mortality and MACE rates were higher in older patients (21.3 vs. 6.0% and 24.9 vs. 11.0%, p <0.0005). In multivariate analysis Killip class II-IV (OR 6.73; 95% CI 1.75-25.97, p=0.006) and heart rate (OR 1.04; 95% CI 1.01-1.07, p=0.03) were independent predictors of one-year mortality in patients aged > or = 75 years.
  
  
  CONCLUSIONS
  Primary PCI in older STEMI patients is associated with a favourable in-hospital and one-year outcome, although inferior to that seen in younger patients. The in-hospital complication rate is similar in the elderly and in younger patients.
authors.affiliation: Haemodynamic Department, Institute of Cardiology, Warsaw, Poland. aciszewski@ikard.pl
authors.forename: Andrzej
authors.initials: A
authors.lastname: Ciszewski
authors.forename: Maciej
authors.initials: M
authors.lastname: Karcz
authors.forename: Cezary
authors.initials: C
authors.lastname: Kepka
authors.forename: Paweł
authors.initials: P
authors.lastname: Bekta
authors.forename: Ewa
authors.initials: E
authors.lastname: Ksiezycka
authors.forename: Jakub
authors.initials: J
authors.lastname: Przyłuski
authors.forename: Artur
authors.initials: A
authors.lastname: Debski
authors.forename: Adam
authors.initials: A
authors.lastname: Witkowski
authors.forename: Witold
authors.initials: W
authors.lastname: Ruzyłło
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D015906:Angioplasty, Balloon, Coronary / Q000401:mortality; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009203:Myocardial Infarction / Q000401:mortality / Q000628:therapy*; D015607:Stents; D015996:Survival Rate; D016896:Treatment Outcome